Review of treatment and complications in 79 children with rattlesnake bite

Clinical Pediatrics

Volumn 47, Issue 5, 2008, Pages 483-489

  Sotelo, Norberto ^a  

^a Hospital Infantil del Estado de Sonora   (Mexico)

Author keywords

Antiviperin serums; Envenoming; Fabotherapy; Hematologic complications; Rattlesnake bite

Indexed keywords

ACETYLSALICYLIC ACID; AMINE; ANALGESIC AGENT; DIPYRIDAMOLE; DIPYRONE; GLUCONATE CALCIUM; GLUCOSAMINE DERIVATIVE; HEPARIN; HYDROCORTISONE; IMMUNOGLOBULIN; KETOROLAC; PARACETAMOL; PENICILLIN G; VENOM ANTISERUM;

ARTICLE; CHILD; COST; FEMALE; HOME; HOSPITALIZATION; HUMAN; HYPOFIBRINOGENEMIA; HYPOPROTHROMBINEMIA; MAJOR CLINICAL STUDY; MALE; SEASON; SEX; SNAKEBITE; STATISTICAL SIGNIFICANCE; SUMMER; SYMPTOM; TIME;

ANIMALS; ANTIVENINS; CHILD; CHILD, PRESCHOOL; CROTALUS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; MEXICO; SEASONS; SNAKE BITES;

EID: 43049092639     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807311734     Document Type: Article

References (30)

1. Russell FE Snake Venom Poisoning. Philadelphia, PA: J. B. Lippincott ; 1980: 139-319.
2. Tay-Zavala J., Díaz-Sánchez J., Sánchez-Vega T., et al. Serpientes y reptiles de importancia médica en México. Rev Fac Med UNAM. 2002 ; 45: 212-216.
3. Julia ZJ Reptiles mexicanos de importancia para la Salud Pública y su distribución geográfica. Salud Publica Mex. 1981 ; 23: 329-342.
4. Sotelo-Cruz N. Mordedura por serpiente venenosa. In: Martínez Panataleón O, ed. Intoxicaciones. Asociación Mexicana de Pediatría. México, DF: McGraw-Hill Interamericana ; 2004: 345-366.
5. Sotelo-Cruz N., García-Alvarez R. Rattlesnake bite complications in 19 children. Pediatr Emerg Care. 1994 ; 10: 30-33.
6. Roodt AR, Estevez-Ramírez J., Paniagua-Solís JF, et al. Toxicidad de venenos de serpientes de importancia médica en México. Gac Med Mex. 2005 ; 141: 13-21.
7. Bjarnson JB, Fox JW Hemorrhagic metalloproteins from snake venom. Pharmacol Ther. 1994 ; 63: 325-331.
8. Gold SB, Barish RA, Dart CR North American snake envenomation: diagnosis and management. Emerg Med Clin North Am. 2004 ; 22: 423-443.
9. Sotelo-Cruz N. El tratamiento de la mordedura por serpientes. Un enfoque práctico. Rev Mex Pediatr. 1997 ; 64: 33-39.
10. Offerman SR, Smith T., Derlet RW Does the aggressive use of polyvalent antivenin for rattlesnake bite result in serious acute side effects ? West Med J. 2001 ; 175: 88-91.
11. JMP [computer program]. Version 5.0.5 (Academic). Cary, NC: SAS Institute ; 2004.
12. Hines WH, Montgomery DC Probabilidad estadística para Ingeniería y Administración. 3 rd ed. México: C.E.C.S.A. ; 1998: 107-111.
13. Dirección General de Planeación Tributaria. Cuotas aplicables a Servicios Médicos Asistenciales. Servicios de Administración Tributaria (SAT). México, DF: Secretaría de Hacienda y Crédito Público (SHCP) ; 1998.
14. Christopher DG, Rodning CB Crotalidae envenomation. South Med J. 1986 ; 79: 159-162.
15. Sotelo-Cruz N., Cruz-Osuna L. Mordedura por serpiente de cascabel en niños. Bol Med Hosp Infant Mex. 1986 ; 43: 558-564.
16. Sotelo-Cruz N. Envenenamiento por mordedura de serpiente de cascabel, daños a la salud y tratamiento en la edad pediátrica. Gac Med Mex. 2003 ; 139: 317-324.
17. Corneille MG, Larson S., Stewart RM, et al. A large single-center experience with treatment of patients with crotalid envenomations: outcome with and evolution of antivenin therapy. Am J Surg. 2006 ; 192: 848-852.
18. Ozay G., Bosnak M., Ece A., et al. Clinical characteristics of children with snakebite poisoning and management of complication in the pediatric intensive care unit. Pediatr Int. 2005 ; 47: 669-675.
19. Owbny CL, Cameron DT, Tu AT Isolation of myotoxic component from a rattlesnake venom. Am J Pathol. 1976 ; 85: 149-153.
20. Yarema MC, Curry SC Envenomation by the northern black tail rattlesnake (Crotalus molossus, molossus): a case report. Pediatr Emerg Care. 2005 ; 21: 40-42.
21. Schmidt JM Antivenom therapy for snakebites in children. Is there evidence? Curr Opin Pediatr. 2005 ; 17: 234-238.
22. Camilleri C., Offerman S., Gosselin R., Alberston T. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation. Clin Toxicol (Phila). 2005 ; 43: 201-206.
23. Boyer LV, Seifest SA, Cain JS Recurrence phenomena after immunoglobulin antivenom therapy for snake envenomation: Part 2. Guidelines for clinical management with crotaline fab antivenom. Ann Emerg Med. 2001 ; 37: 196-201.
24. Dart RC, McNally J. Efficacy, safety and use snake antivenom in the United States. Ann Emerg Med. 2001 ; 37: 181-188.
25. Seger D., Kahn S., Krenzelok EP Treatment of US crotalid bites. Comparison of serum and globulin-based polyvalent and antigen-binding fragment antivenins. Toxicol Rev. 2005 ; 24: 217-227.
26. Richardon WH III, Tanen DA, Tong TC, et al. Crotalidae polyvalentimmune FAB (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model. Ann Emerg Med. 2005 ; 45: 595-602.
27. Wasserberger J., Ordog G., Merkin TE Southern Pacific rattlesnake bite: a unique clinical challenge. J Emerg Med. 2006 ; 31: 263-266.
28. Sánchez EE, Galán JA, Pérez JC, Rodríguez- Acosta A., Chase BP, Pérez JC The efficacy of two antivenoms against the venom of North American snakes. Toxicon. 2003 ; 41: 357-365.
29. García-Willis CE, Rivas-Castelón AR Experiencia en el manejo de pacientes con mordedura de víbora en el Hospital General de Tampico. Reporte de 210 casos. Med Int Mex. 1997 ; 13: 268-271.
30. Frayre-Torres MJ, Sevilla-Godínez E., Orozco-Valerio MDE, Armas J., Celis A. Mortalidad por contacto con serpientes y lagartos venenosos en México de 1979-2003. Gac Med Mex. 2006 ; 42: 209-213.